Louise Moon

Louise Moon, Bloomberg Breaking News editor, shares insights on major market developments. Novo Nordisk is facing challenges, cutting its forecast due to declining sales of its weight-loss drugs. Meanwhile, Orsted aims to calm investors with assurances after a tough quarter and ongoing US project issues. Marks & Spencer is on the rebound, reporting stronger profits despite the setback from a recent cyberattack, with optimistic projections for the second half of the year. Moon’s analysis reveals the critical shifts affecting these companies.

Louise Moon, a Bloomberg breaking news editor with expertise in European stocks, dives into the latest corporate shifts. She discusses the potential separation of Primark from AB Foods and the positive outlook it brings. Louise also analyzes Telefonica’s dramatic share plunge following a major dividend cut strategy. In contrast, Royal Philips sees a stock rise fueled by better-than-expected quarterly results and strong US demand. Tune in for insightful stock market dynamics and corporate strategies!

Louise Moon, Breaking News Editor at Bloomberg, shares her insights on the latest movements in European stocks. She highlights NatWest's impressive Q3 performance, attributing its surge to a decade-high profit and strong cost control. In contrast, GSK faces challenges after its blood cancer drug approval raised concerns over sales potential. Meanwhile, Accor celebrates a positive earnings report and boosts confidence by announcing a €100 million buyback, showcasing its commitment to financial discipline.